Lupus (SLE) trials in Guatemala
1 of 3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleINTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
- Where
- Guatemala City
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06314282